Remote ultrasonic robot made by MGI On February 16th, the "Remote Ultrasound Robot" independently developed by MGI Remote Ultrasound Diagnostic System was delivered to Wuhan Huangpi Fangcai Hospital; on February 17, the remote ultrasonic robot was delivered to Lei Shenshan Hospital. As of February 18, all the remote ultrasound equipment headed to the epidemic area have completed the installation, commissioning and training, and quickly supported the ultrasound inspection work in the epide...

MGI, a member of global genomics leader BGI Group, has expanded its DNA sequencing and laboratory automation products available in Latin America, signing agreements with top distributors in Brazil, Argentina, Peru, Ecuador, Colombia and Mexico. Through these experienced partners, MGI will be able to immediately offer its products for the research, clinical/diagnostics and other markets. Distributors have acquired MGI sequencers and other instruments to offer local demonstrations and train...

The nucleic acid test of 2019-novel coronavirus (2019-nCoV, now was named as COVID-19 suggested by WHO) is an essential reference for clinical diagnosis and discharge of patients, and an important evidence for whom with close contact to confirmed case under quarantine to be released. The "Huo-Yan " laboratory with daily testing capacity of 10,000 samples can provide sufficient testing capabilities for Wuhan and surrounding cities, for the diagnosis of patients with fever, the screening of...

Since the outbreak of the novel coronavirus pneumonia, nucleic acid testing has been an important diagnostic basis for clinical diagnosis, release from isolation, and rehabilitation and discharge from hospital. With the further development of the epidemic situation, the anti-epidemic "battlefield" needs to face more complex areas and usage scenarios, and has further requirements for detection equipment and technology. In order to meet the needs of "mobile real-time detection,” MGI has ...

Last month, Wang Jian, co-founder and chairman of BGI Group, went to the frontlines to support prevention and control of the 2019-nCoV outbreak in Wuhan. "Precise nucleic acid testing is an important basis for clinical diagnosis and discharge of recovered patients, as well as ending isolation of contacts,” he said, pointing to the urgent need for a testing center that can process a large volume of samples daily. On February 5, the Huo-Yan Laboratory, an emergency test laboratory run by B...

On February 5, the Huo-Yan Laboratory, an emergency test laboratory run by BGI and designed to handle 10,000 samples daily to detect 2019-nCoV, officially started trial operation in Wuhan. The lab will greatly increase the speed of testing novel coronavirus cases so that suspected infections can be eliminated or confirmed as soon as possible. The Huo-Yan or “Fire Eye” laboratory was jointly established by the Wuhan Municipal Government, Wuhan East Lake High-Tech Development Zone,CCCC S...